Recommendations for reimbursement of personalised medicines
Guideline
Recommendations outlining key actions for the reimbursement of personalised medicines and proposed timeframes for their implementation.
- Project
- HEcoPerMed
- Funding
- Horizon 2020
- Project status
- Completed 2022
- HTA domains
- Aspects Beyond HTA
- Categories
- Pricing/Payer
- Technology
- Medicines
Similar by meaning
Beta record. Based on the original catalogue summary; primary-source enrichment pending.

